课题基金 / 基金详情

Immunity to Virus-induced Tumors

Immunity to Virus-induced Tumors
对病毒诱发的肿瘤的免疫力
批准号:
6738647
负责人:
VAIVA D VEZYS
金额:
$4.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-13 至 2006-04-12

项目摘要

项目成果

VAIVA D VEZYS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):病毒是癌症起始的致病因素。CD8 T细胞的持续监测控制着肿瘤的生长。最佳的CD8 T细胞反应需要CD4 T细胞的帮助。在T细胞的细胞因子分泌模式中可以看到一个广义的二分法,称为Th1和Th2。这些细胞因子与CD8 T细胞功能相互作用的结果尚不完全清楚,但可能具有相反的功能作用。小鼠是多瘤病毒(一种致癌DNA病毒)的天然宿主。最近有研究表明,CD94/NKG2A受体可阻断多瘤特异性CD8 T细胞的裂解活性。细胞因子和/或抗原可控制这种抑制性受体的表达。初步研究表明来自肿瘤易感的T细胞产生IL-4。因此,我们假设显性Th2 CD4 T细胞反应通过调节抑制受体CD94/NKG2A对多瘤特异性CD8 T细胞的裂解活性产生负面影响。特异性目的:确定CD4 T细胞及其细胞因子分泌谱对肿瘤抵抗和肿瘤易感小鼠的影响;了解CD94/NKG2A的调控因子。CD4 T细胞的细胞因子表达谱将使用elispot进行定量分析。将表达不同水平CD94/NKG2A的多瘤特异性CD8 T细胞转移到未感染的动物或感染了抗原无关病毒的动物身上。我们将在宿主动物中监测CD94/NKG2A的表达和功能,以确定该受体上调的需求和功能。这些研究将阐明其作用。多种因素在强效抗肿瘤CD8 T细胞的产生和维持中起作用。这一信息有助于开发刺激CD8 T细胞根除癌症的治疗干预措施。
英文摘要
DESCRIPTION (provided by applicant): Viruses are causative factors in cancer initiation. Constant surveillance by CD8 T cells controls the outgrowth of tumors. Optimal CD8 T cell responses require help from CD4 T cells. A generalized dichotomy can be seen in cytokine secretion patterns from T cells, termed Th1 and Th2. The outcomes of the interactions of these cytokines with CD8 T cell functions are not completely understood, but may have opposing functional effects. The mouse is a natural host for polyoma virus, an oncogenic DNA virus. Recently, it was shown that the CD94/NKG2A receptor blocks the lytic activity of polyoma-specific CD8 T cells. Cytokines and/or antigen, may control expression of this inhibitory receptor. Preliminary studies indicate that T cells from tumor-susceptible produce IL-4. Therefore, we hypothesize that a dominant Th2 CD4 T cell response negatively impacts on the lytic activity of polyoma-specific CD8 T cells through modulation of the inhibitory receptor, CD94/NKG2A. Specific aims: To determine the impact CD4 T cells and their cytokine secretion profiles in tumor-resistant and tumor-susceptible mice; to understand factors controlling the regulation of CD94/NKG2A. Cytokine expression profiles of CD4 T cells will be quantitated using Elispots. Transfer of polyoma-specific CD8 T cells, which express different levels of CD94/NKG2A, into uninfected animals or animals infected with an antigenically irrelevant virus will be done. CD94/NKG2A expression and function will be monitored in the host animals to determine requirements for upregulation and function of this receptor. These studies will elucidate the role. Various factors play in the generation and maintenance of potent anti-tumor CD8 T cells. This information can aid in the development of therapeutic interventions to stimulate CD8 T cells for cancer eradication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of reduced T cell autoimmunity with immune experience
  • 批准号:
    10632556
  • 项目类别:
  • 资助金额:
    $40.87万
  • 财政年份:
    2022
  • 负责人:
    VAIVA D VEZYS
  • 依托单位:
Therapeutic vaccination targeting SIV viral reservoirs
  • 批准号:
    8842310
  • 项目类别:
  • 资助金额:
    $24.02万
  • 财政年份:
    2014
  • 负责人:
    VAIVA D VEZYS
  • 依托单位:
Therapeutic vaccination targeting SIV viral reservoirs
  • 批准号:
    8930062
  • 项目类别:
  • 资助金额:
    $18.9万
  • 财政年份:
    2014
  • 负责人:
    VAIVA D VEZYS
  • 依托单位:
Understanding the Persistence of Immune-mediated Chronic Diseases
  • 批准号:
    7849263
  • 项目类别:
  • 资助金额:
    $226.5万
  • 财政年份:
    2009
  • 负责人:
    VAIVA D VEZYS
  • 依托单位:
国内基金
海外基金
Shp2 在polyomavirus middle T antigen(mT)诱发肿瘤过程中的作用
  • 批准号:
    30700392
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2007
  • 负责人:
    杨瑛
  • 依托单位: